The PCOS Stack: Inositol, Vitamin D, NAC, and Omega-3

Polycystic ovary syndrome is the most common endocrine disorder of reproductive-age women, and supplements have a real evidence-supported role alongside lifestyle and metformin. The 2023 International PCOS Guideline endorses inositol as a non-pharmaceutical option for metabolic features. Four components have the strongest trial evidence for restoring ovulation, lowering free androgens, and improving insulin sensitivity: myo + d-chiro inositol in a 40:1 ratio, vitamin D to repletion, N-acetylcysteine, and EPA-dominant omega-3.

Layer 1: Myo-Inositol + D-Chiro Inositol, 40:1 Ratio (2 g + 50 mg Twice Daily)

The 40:1 combination — which roughly mirrors the physiological plasma ratio — has the most consistent positive trial record. A 2017 meta-analysis of 9 RCTs found that inositol supplementation improved insulin sensitivity (HOMA-IR), lowered fasting glucose, restored ovulation in 60–70% of treated women versus 20–30% in placebo, and reduced free testosterone. The mechanistic story is plausible: inositol-derived second messengers signal downstream of insulin receptors, and PCOS appears to involve a tissue-specific impairment of inositol metabolism. High-dose pure d-chiro alone can worsen oocyte quality and should be avoided. See the inositol combination evidence page and the PCOS condition page for the wider context.

Layer 2: Vitamin D3 to a Serum 25-OH-D of 30–50 ng/mL

Vitamin D deficiency is prevalent in PCOS (60–80% of women with PCOS have serum 25-OH-D below 20 ng/mL in published series). A 2019 meta-analysis of 11 RCTs found that repletion improved insulin sensitivity, lowered total testosterone, and modestly improved menstrual regularity versus placebo. The signal is strongest in women who start frankly deficient — supplementation in already-replete women does little. Dose to a target serum level rather than to a fixed daily intake; 2,000–4,000 IU daily is a reasonable starting dose with retesting at 12 weeks. See our vitamin D dose guide for the testing logic.

Layer 3: N-Acetylcysteine (NAC), 1,800 mg Daily

NAC has surprisingly strong PCOS evidence. Head-to-head trials of NAC 1,800 mg daily versus metformin 1,500 mg have shown comparable improvements in insulin sensitivity, ovulation rate, and androgen reduction over 3–6 months, with a much better GI tolerability profile. A 2015 meta-analysis of 8 RCTs concluded that NAC significantly improved ovulation and pregnancy rates in women with PCOS undergoing clomiphene induction. NAC is not a substitute for metformin in women who specifically need glycemic management for type 2 diabetes risk, but it is a reasonable first-line option for women who didn't tolerate metformin or who want to try a non-pharmaceutical route first. See the NAC dossier.

Layer 4: EPA-Dominant Omega-3, 1.5–3 g EPA + DHA Daily

The omega-3 PCOS evidence is smaller-effect but consistent. A 2018 meta-analysis of 9 RCTs found that omega-3 supplementation at 1–4 g daily for 8–12 weeks reduced total testosterone, lowered LH:FSH ratio, and improved insulin sensitivity. The mechanism likely involves SHBG upregulation (raising bound testosterone, lowering bioavailable) and direct effects on insulin signalling. EPA-dominant products (60:40 EPA:DHA or higher) appear slightly more effective than DHA-dominant for the metabolic features. This layer also addresses the elevated cardiovascular risk and depressive symptoms common in PCOS. See our broader omega-3 depression analysis.

What NOT to Add

Berberine has emerging evidence and may be added cautiously for women with prominent insulin resistance, but watch for GI side effects and CYP3A4 interactions. Avoid spearmint tea as an "anti-androgen" — the effect on testosterone is small and inconsistent in trials. DHEA is contraindicated in PCOS (it converts to androgens). Saw palmetto is not adequately studied for female anti-androgenic use. Skip "ovary detox" and "estrogen detox" blends entirely — no real mechanism, no real data.

How to Run the Stack

Start with inositol alone for the first 8 weeks; this is the highest-yield component and confounds attribution if added later. Check 25-OH-D at week 0 and start vitamin D dosing to repletion. Add NAC at week 8 if ovulation hasn't resumed and HOMA-IR is still high. Add omega-3 from the start if you are also using it for cardiometabolic prevention. Re-evaluate menstrual regularity, fasting insulin, and free androgen index at 6 months. Inositol is generally safe in pregnancy; NAC and high-dose vitamin D require obstetric input if trying to conceive.

Bottom Line

This stack has the strongest evidence base of any supplement protocol for a hormonal disorder. The inositol layer is doing most of the work; the other three are useful adjuncts. None of it substitutes for the foundational lifestyle interventions (weight management where applicable, resistance training, sleep) or for metformin and combined oral contraceptives when those are clinically indicated.